Search Results - Drugs

Antiviral drugs (non-HIV)

Table of Contents: “…Contents: Why do we need antiviral drugs? -- Overview of approved antiviral drugs -- Antiviral targets mechanisms and resistance -- Hepatitis C virus: biology and current drugs -- Hepatitis B virus: biology and treatments -- Herpesvirus drugs -- Influenza virus: approved drugs -- Broad-spectrum antivirals -- Diseases for which we need antivirals.…”
Get full text
Series

Antiviral drugs (non-HIV)

Table of Contents: “…Contents: Why do we need antiviral drugs? -- Overview of approved antiviral drugs -- Antiviral targets mechanisms and resistance -- Hepatitis C virus: biology and current drugs -- Hepatitis B virus: biology and treatments -- Herpesvirus drugs -- Influenza virus: approved drugs -- Broad-spectrum antivirals -- Diseases for which we need antivirals.…”
Get full text
Series

Antiviral drugs (non-HIV)

Table of Contents: “…Contents: Why do we need antiviral drugs? -- Overview of approved antiviral drugs -- Antiviral targets mechanisms and resistance -- Hepatitis C virus: biology and current drugs -- Hepatitis B virus: biology and treatments -- Herpesvirus drugs -- Influenza virus: approved drugs -- Broad-spectrum antivirals -- Diseases for which we need antivirals.…”
Get full text
Series

Drugs, society & human behavior / by Hart, Carl L., Ksir, Charles

Table of Contents: “…Drug use : an overview -- Drug use as a social problem -- Drug policy -- The nervous system -- The actions of drugs -- Stimulants -- Depressants and inhalants -- Medication for mental disorders -- Alcohol -- Tobacco -- Caffeine -- Dietary supplements and over-the-counter drugs -- Opioids -- Hallucinogens -- Marijuana -- Performance-enhancing drugs -- Preventing substance -- Treating substance use disorders.…”

Gastrointestinal drug delivery

Table of Contents: “…Contents: Anatomy of the gastrointestinal tract -- Principles of drug absorption in the gastrointestinal tract -- Physiological and pharmaceutical factors influencing drug delivery -- Routes for drug delivery in the gastrointestinal tract -- Drug targeting in the stomach, small intestine, and colon.…”
Get full text
Series

Gastrointestinal drug delivery

Table of Contents: “…Contents: Anatomy of the gastrointestinal tract -- Principles of drug absorption in the gastrointestinal tract -- Physiological and pharmaceutical factors influencing drug delivery -- Routes for drug delivery in the gastrointestinal tract -- Drug targeting in the stomach, small intestine, and colon.…”
Get full text
Series

Drug metabolism in liver disease

Table of Contents: “…Contents: Drug metabolism -- Liver disease and drug clearance -- Mechanistic explanations -- Intact hepatocyte hypothesis -- Sequential progressive model of liver disease -- Liver disease etiology -- Liver disease severity -- Epigenetics -- Biomarkers.…”
Get full text
Series

Drug-induced liver injury risk factors and drug development in DILI /

Table of Contents: “…Contents: DILI risk factors -- Racial differences in DILI -- Statin use -- Drug metabolism -- Genetic risk factors for DILI -- Outcomes for DILI -- Regulatory science -- Hy's law and eDISH.…”
Get full text
Series (Periodic reports)
Series (Gastroenterology and hepatology)

Drug-induced liver injury HDS, diagnosing, treating and preventing DILI /

Subjects: Get full text
Series (Periodic reports)
Series (Gastroenterology and hepatology)

Need for drug delivery systems part 2 /

Table of Contents: “…Contents: The need for delivery system in oncology -- Lipid-based nanotechnologies: a clinical reality -- Improving biodistribution and pharmacokinetics and safety -- Improving therapeutic outcome upon increasing drug release at target organ -- Targeting tumor microenvironment at two different cell levels -- Improving formulation.…”
Get full text
Series

Drug metabolism in liver disease

Table of Contents: “…Contents: Drug metabolism -- Liver disease and drug clearance -- Mechanistic explanations -- Intact hepatocyte hypothesis -- Sequential progressive model of liver disease -- Liver disease etiology -- Liver disease severity -- Epigenetics -- Biomarkers.…”
Get full text
Series

Drug metabolism in liver disease

Table of Contents: “…Contents: Drug metabolism -- Liver disease and drug clearance -- Mechanistic explanations -- Intact hepatocyte hypothesis -- Sequential progressive model of liver disease -- Liver disease etiology -- Liver disease severity -- Epigenetics -- Biomarkers.…”
Get full text
Series

Need for drug delivery systems part 2 /

Table of Contents: “…Contents: The need for delivery system in oncology -- Lipid-based nanotechnologies: a clinical reality -- Improving biodistribution and pharmacokinetics and safety -- Improving therapeutic outcome upon increasing drug release at target organ -- Targeting tumor microenvironment at two different cell levels -- Improving formulation.…”
Get full text
Series

Drug-induced liver injury risk factors and drug development in DILI /

Table of Contents: “…Contents: DILI risk factors -- Racial differences in DILI -- Statin use -- Drug metabolism -- Genetic risk factors for DILI -- Outcomes for DILI -- Regulatory science -- Hy's law and eDISH.…”
Get full text
Series (Periodic reports)
Series (Gastroenterology and hepatology)

Drug-induced liver injury HDS, diagnosing, treating and preventing DILI /

Subjects: Get full text
Series (Periodic reports)
Series (Gastroenterology and hepatology)

Current trends in antiviral drug development

Subjects: Get full text
Series (Antivirals)
Series (Small molecule drug discovery)

Current trends in antiviral drug development

Subjects: Get full text
Series (Antivirals)
Series (Small molecule drug discovery)

Current trends in antiviral drug development

Subjects: Get full text
Series (Antivirals)
Series (Small molecule drug discovery)

Inhibiting protein-protein interactions part 2 of 2 /

Table of Contents: “…Contents: A different view of druggability -- Five propositions about the druggability of PPI targets -- Protein-ligand binding energy -- Ligand efficiency and drug-target binding -- ADME & druglikeness considerations -- Conventional view of druglikeness -- Druggability and chemical space -- Targeting low druggability PPI -- Macrocycles -- Covalent inhibitors -- Foldamers.…”
Get full text
Series

G-Protein coupled receptors in drug discovery

Table of Contents: “…Contents: The G-protein coupled receptor superfamily -- GPCRs as drug targets -- Approved GPCR drugs -- Why the reduction in GPCR drugs -- New screening technologies and new drug targets.…”
Get full text
Series